Amelioration of ischemia-reperfusion-induced muscle injury by the recombinant human MG53 protein

Muscle and Nerve

Volumn 52, Issue 5, 2015, Pages 852-858

  Zhu, Hua ^a   Hou, Jincai ^b   Roe, Janet L ^c   Park, Ki Ho ^a   Tan, Tao ^d   Zheng, Yongqiu ^b   Li, Lei ^b   Zhang, Cuixiang ^b   Liu, Jianxun ^b   Liu, Zhenguo ^a   Ma, Jianjie ^a,d   Walters, Thomas J ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b XIYUAN HOSPITAL   (China)

^c US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^d TRIM edicine Inc ^*  (United States)

Author keywords

Creatine kinase; Edema; Muscle injury; Tourniquet; TRIM72

Indexed keywords

CAVEOLIN 3; CREATINE KINASE; DYSFERLIN; MUSCLE PROTEIN; RECOMBINANT HUMAN MITSUGUMIN 53 PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; MITSUGUMIN 53, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; HEART MUSCLE ISCHEMIA; INTRACELLULAR MEMBRANE; ISCHEMIA REPERFUSION INJURY INDUCED MUSCLE INJURY; MALE; MEMBRANE DAMAGE; MOUSE; MUSCLE CELL; MUSCLE FIBER MEMBRANE; MUSCLE INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; REPERFUSION INJURY; SKELETAL MUSCLE; TAIL VEIN; THERAPY EFFECT; WILD TYPE; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECTS; HUMAN; INJURIES; KNOCKOUT MOUSE; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CARRIER PROTEINS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; REPERFUSION INJURY;

EID: 84943201302     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24619     Document Type: Article

References (31)

1. Owens BD, Kragh JF Jr, Macaitis J, Svoboda SJ, Wenke JC. Characterization of extremity wounds in Operation Iraqi Freedom and Operation Enduring Freedom. J Orthop Trauma 2007;21:254-257.
2. White JM, Stannard A, Burkhardt GE, Eastridge BJ, Blackbourne LH, Rasmussen TE. The epidemiology of vascular injury in the wars in iraq and afghanistan. Ann Surg 2011;253:1184-1189.
3. Ritenour AE, Dorlac WC, Fang R, Woods T, Jenkins DH, Flaherty SF, et al. Complications after fasciotomy revision and delayed compartment release in combat patients. J Trauma 2008;64(Suppl):S153-s161; discussion S161-S162.
4. Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg 2002;10:620-630.
5. Criswell TL, Corona BT, Ward CL, Miller M, Patel M, Wang Z, et al. Compression-induced muscle injury in rats that mimics compartment syndrome in humans. Am J Pathol 2012;180:787-797.
6. Heppenstall RB, Scott R, Sapega A, Park YS, Chance B. A comparative study of the tolerance of skeletal muscle to ischemia. Tourniquet application compared with acute compartment syndrome. J Bone Joint Surg Am 1986;68:820-828.
7. Bolcal C, Yildirim V, Doganci S, Sargin M, Aydin A, Eken A, et al. Protective effects of antioxidant medications on limb ischemia reperfusion injury. J Surg Res 2007;139:274-279.
8. Walters TJ, Mase VJ Jr, Roe JL, Dubick MA, Christy RJ. Poloxamer-188 reduces muscular edema after tourniquet-induced ischemia-reperfusion injury in rats. J Trauma 2011;70:1192-1197.
9. Byrnes KR, Fricke ST, Faden AI. Neuropathological differences between rats and mice after spinal cord injury. J Magn Reson Imaging 2010;32:836-846.
10. Sroga JM, Jones TB, Kigerl KA, McGaughy VM, Popovich PG. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J Comp Neurol 2003;462:223-240.
11. Parker JC, Townsley MI. Evaluation of lung injury in rats and mice. Am J Physiol Lung Cell Mol Physiol 2004;286:L231-L246.
12. McGill MR, Williams CD, Xie Y, Ramachandran A, Jaeschke H. Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicol Appl Pharmacol 2012;264:387-394.
13. Cai C, Masumiya H, Weisleder N, Matsuda N, Nishi M, Hwang M, et al. MG53 nucleates assembly of cell membrane repair machinery. Nat Cell Biol 2009;11:56-64.
14. Lek A, Evesson FJ, Lemckert FA, Redpath GM, Lueders AK, Turnbull L, et al. Calpains, cleaved mini-dysferlinC72, and L-type channels underpin calcium-dependent muscle membrane repair. J Neurosci 2013;33:5085-5094.
15. Cai C, Weisleder N, Ko JK, Komazaki S, Sunada Y, Nishi M, et al. Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin. J Biol Chem 2009;284:15894-15902.
16. Weisleder N, Takizawa N, Lin P, Wang X, Cao C, Zhang Y, et al. Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy. Sci Transl Med 2012;4:139ra185.
17. Weisleder N, Lin P, Zhao X, Orange M, Zhu H, Ma J. Visualization of MG53-mediated cell membrane repair using in vivo and in vitro systems. J Vis Exp 2011;pii:2717.
18. Corona BT, Garg K, Roe JL, Zhu H, Park KH, Ma J, et al. The effect of recombinant human MG53 protein on tourniquet-induced ischemia reperfusion injury in rat muscle. Muscle Nerve 2014;49:919-921.
19. Wang X, Xie W, Zhang Y, Lin P, Han L, Han P, et al. Cardioprotection of ischemia/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair. Circ Res 2010;107:76-83.
20. Cao CM, Zhang Y, Weisleder N, Ferrante C, Wang X, Lv F, et al. MG53 constitutes a primary determinant of cardiac ischemic preconditioning. Circulation 2010;121:2565-2574.
21. Zhang Y, Lv F, Jin L, Peng W, Song R, Ma J, et al. MG53 participates in ischaemic postconditioning through the RISK signalling pathway. Cardiovasc Res 2011;91:108-115.
22. Percival TJ, White JM, Ricci MA. Compartment syndrome in the setting of vascular injury. Perspect Vasc Surg Endovasc Ther 2011;23:119-124.
23. Lovering RM, De Deyne PG. Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contraction-induced injury. Am J Physiol Cell Physiol 2004;286:C230-C238.
24. Sleet DA, Moffett DB. Framing the problem: injuries and public health. Fam Community Health 2009;32:88-97.
25. Owens BD, Kragh JF Jr, Wenke JC, Macaitis J, Wade CE, Holcomb JB. Combat wounds in operation Iraqi Freedom and operation Enduring Freedom. J Trauma 2008;64:295-299.
26. Gifford SM, Eliason JL, Clouse WD, Spencer JR, Burkhardt GE, Propper BW, et al. Early versus delayed restoration of flow with temporary vascular shunt reduces circulating markers of injury in a porcine model. J Trauma 2009;67:259-265.
27. Fox CJ, Gillespie DL, Cox ED, Mehta SG, Kragh JF Jr, Salinas J, et al. The effectiveness of a damage control resuscitation strategy for vascular injury in a combat support hospital: results of a case control study. J Trauma 2008;64(Suppl):S99-S106; discussion S106-S107.
28. Cai C, Masumiya H, Weisleder N, Pan Z, Nishi M, Komazaki S, et al. MG53 regulates membrane budding and exocytosis in muscle cells. J Biol Chem 2009;284:3314-3322.
29. Weisleder N, Takeshima H, Ma J. Mitsugumin 53 (MG53) facilitates vesicle trafficking in striated muscle to contribute to cell membrane repair. Commun Integr Biol 2009;2:225-226.
30. Jia Y, Chen K, Lin P, Lieber G, Nishi M, Yan R, et al. Treatment of acute lung injury by targeting MG53-mediated cell membrane repair. Nat Commun 2014;5:4387.
31. Cea LA, Cisterna BA, Puebla C, Frank M, Figueroa XF, Cardozo C, et al. De novo expression of connexin hemichannels in denervated fast skeletal muscles leads to atrophy. Proc Natl Acad Sci U S A 2013;110:16229-16234.